Equillium CEO Bruce Steel: We are among the few evaluated in first-line GVHD treatment
What is Equillium all about? We started the company four years ago around our lead drug program itolizumab. My colleague,...
Health Care
Rite Aid Corporation (RAD) Q3 2022 Earnings Call Transcript
Rite Aid Corporation (NYSE: RAD) Q3 2022 earnings call dated Dec. 21, 2021 Corporate Participants: Trent Kruse — Senior Vice President of...
HEXO Corp. (HEXO) Q1 2022 Earnings Call
HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith — Director, Investor Relations Scott Cooper — President, Chief...
HEXO Corp. (HEXO) Q1 2022 Earnings Call Transcript
HEXO Corp. (NYSE: HEXO) Q1 2022 earnings call dated Dec. 14, 2021 Corporate Participants: Jennifer Smith — Director, Investor Relations Scott Cooper — President,...
Champions Oncology, Inc. (CSBR) Q2 2022 Earnings Call Transcript
Champions Oncology, Inc. (NASDAQ: CSBR) Q2 2022 earnings call dated Dec. 13, 2021. Corporate Participants: Ronnie Morris — President & Chief Executive...
Merck & Co. (MRK) stock research summary | Q3 2021
Merck is a multinational pharmaceutical company which announced its earnings call on October 28, 2021. Merck beat Zacks consensus on...
Biofrontera sees TAM of $4 Bln for lead product Ameluz: CEO Erica Monaco
Biofrontera Inc. (Nasdaq: BFRI) is a biopharmaceutical company providing specialty dermatology therapies and services in the United States. Founded in...
Avid Bioservices, Inc. (CDMO) Q2 2022 Earnings Call Transcript
Avid Bioservices, Inc. (NASDAQ: CDMO) Q2 2022 earnings call dated Dec. 07, 2021 Corporate Participants: Tim Brons — Investor Relations, Vida Strategic...
HealthEquity, Inc. (HQY) Q3 2021 Earnings Call Transcript
HealthEquity, Inc. (NASDAQ: HQY) Q3 2021 earnings call dated Dec. 06, 2021 Corporate Participants: Richard Putnam — Investor Relations Jon Kessler — President/Chief Executive...
Eli Lilly and Company (LLY) Earnings: 3Q21 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported revenue of $6.7 billion for the third quarter of 2021, up 18% year-over-year....
IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO
After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed...
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments...
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of...
Patterson Companies, Inc. (PDCO) Q2 2022 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q2 2022 earnings call dated Dec. 01, 2021 Corporate Participants: John M. Wright — Vice President, Investor...
Biofrontera Inc (BFRI) Q3 2021 Earnings Call Transcript
Biofrontera Inc (NASDAQ: BFRI) Q3 2021 earnings call dated Nov. 30, 2021 Corporate Participants: Pamela Keck — Head of Investor Relations...
BMY Earnings: Key quarterly highlights from Bristol-Myers Squibb Q3 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to...
Centogene N.V. (CNTG) Q3 2021 Earnings Call Transcript
Centogene N.V. (NASDAQ: CNTG) Q3 2021 earnings call dated Nov. 24, 2021 Corporate Participants: Lennart Streibel — Investor Relations Andrin Oswald — Chief Executive...
Bausch Health Companies Inc. (BHC) stock research summary | Q3 2021
Bausch Health (NYSE: BHC) was negatively impacted by the COVID-19 pandemic as most of its products are dependent on elective...
Medtronic PLC (MDT) Q2 2022 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q2 2022 earnings call dated Nov. 23, 2021 Corporate Participants: Ryan Weispfenning — Vice President and Head –...
Colgate-Palmolive Company (CL) earnings Q3 2021 results
Colgate-Palmolive Company (NYSE: CL) reported its third-quarter financial results for the period ended September 30, 2021. GAAP net income for...
Vertex Pharma (VRTX) expands cystic fibrosis pipeline; raises FY21 outlook
Biotechnology company Vertex Pharmaceuticals (NASDAQ: VRTX) has reported higher earnings and revenues for the third quarter of 2021. The bottom...